1067659-31-7

Basic information

• Product Name: 2-(1,4'-bipiperidin-1'-yl)ethanamine
• Synonyms: 2-(1,4'-bipiperidin-1'-yl)ethanamine;2-(4-piperidin-1-ylpiperidin-1-yl)ethanamine;2-(4-piperidino-1-piperidyl)ethylamine;2-[4-(1-piperidyl)-1-piperidinyl]ethanamine;2-[4-(1-piperidyl)-1-piperidyl]ethanamine
• CAS NO: 1067659-31-7
• Molecular Formula: C12H25N3
• Molecular Weight: 211.347
• Mol File: 1067659-31-7.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-(1,4'-bipiperidin-1'-yl)ethanamine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(1,4'-bipiperidin-1'-yl)ethanamine(1067659-31-7)
• EPA Substance Registry System: 2-(1,4'-bipiperidin-1'-yl)ethanamine(1067659-31-7)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 1067659-31-7(Hazardous Substances Data)

Usage

Type of compound

Piperidine derivative A compound derived from piperidine, which is a heterocyclic amine.

Usage

Intermediate in the synthesis of pharmaceuticals and organic compounds The compound is commonly used as a building block in creating various medications and organic substances.

Applications

Research and development, particularly in medicinal chemistry It may be used in the study and creation of new drugs and chemical compounds.

Physical appearance

Clear, colorless liquid with a characteristic amine odor The compound's visual and olfactory properties.

Solubility

Soluble in water and ethanol The compound can dissolve in these solvents, making it easier to work with in various chemical reactions.

Hazardous properties

Requires proper management to avoid potential hazards The compound may pose risks if not handled correctly, emphasizing the importance of safety precautions.

Relevant articles and documents

3-IMIDAZOLYL-INDOLES FOR THE TREATMENT OF PROLIFERATIVE DISEASES

The invention relates to 3-heterocyclyl indolyl compounds capable of inhibiting the interaction between p53, or variants thereof, and MDM2 and/or MDM4, or variants thereof, respectively, said compounds having the formula (I) wherein R1, R2, R3, R4, RA, Y and Y are as defined in the specification. Due to their activity, the compounds are useful in the treatment of various disorders and diseases mediated by the activity of MDM2 and/or MDM4, or variants thereof, such as inflammatory or proliferative diseases or in the protection of cells.